SwePub
Tyck till om SwePub Sök här!
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Shin JI) srt2:(2015-2019)"

Sökning: WFRF:(Shin JI) > (2015-2019)

  • Resultat 1-10 av 23
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  •  
2.
  •  
3.
  •  
4.
  • Jeong, Gwang Hun, et al. (författare)
  • Incidence of Capillary Leak Syndrome as an Adverse Effect of Drugs in Cancer Patients: A Systematic Review and Meta-Analysis
  • 2019
  • Ingår i: Journal of Clinical Medicine. - : MDPI. - 2077-0383. ; 8:2
  • Forskningsöversikt (refereegranskat)abstract
    • Capillary leak syndrome (CLS) is a rare disease with profound vascular leakage, which can be associated with a high mortality. There have been several reports on CLS as an adverse effect of anti-cancer agents and therapy, but the incidence of CLS according to the kinds of anti-cancer drugs has not been systemically evaluated. Thus, the aim of our study was to comprehensively meta-analyze the incidence of CLS by different types of cancer treatment or after bone marrow transplantation (BMT). We searched the literatures (inception to July 2018) and among 4612 articles, 62 clinical trials (studies) were eligible. We extracted the number of patients with CLS, total cancer patients, name of therapeutic agent and dose, and type of cancer. We performed a meta-analysis to estimate the summary effects with 95% confidence interval and between-study heterogeneity. The reported incidence of CLS was categorized by causative drugs and BMT. The largest number of studies reported on CLS incidence during interleukin-2 (IL-2) treatment (n = 18), which yielded a pooled incidence of 34.7% by overall estimation and 43.9% by meta-analysis. The second largest number of studies reported on anti-cluster of differentiation (anti-CD) agents (n = 13) (incidence of 33.9% by overall estimation and 35.6% by meta-analysis) or undergoing BMT (n = 7 (21.1% by overall estimation and 21.7% by meta-analysis). Also, anti-cancer agents, including IL-2 + imatinib mesylate (three studies) and anti-CD22 monoclinal antibodies (mAb) (four studies), showed a dose-dependent increase in the incidence of CLS. Our study is the first to provide an informative overview on the incidence rate of reported CLS patients as an adverse event of anti-cancer treatment. This meta-analysis can lead to a better understanding of CLS and assist physicians in identifying the presence of CLS early in the disease course to improve the outcome and optimize management.
  •  
5.
  •  
6.
  •  
7.
  • Aad, G., et al. (författare)
  • 2015
  • Tidskriftsartikel (refereegranskat)
  •  
8.
  •  
9.
  • Chung, Hannah, et al. (författare)
  • Bio-based production of monomers and polymers by metabolically engineered microorganisms
  • 2015
  • Ingår i: Current Opinion in Biotechnology. - : Elsevier. - 0958-1669 .- 1879-0429. ; 36, s. 73-84
  • Forskningsöversikt (refereegranskat)abstract
    • Recent metabolic engineering strategies for bio-based production of monomers and polymers are reviewed. In the case of monomers, we describe strategies for producing polyamide precursors, namely diamines (putrescine, cadaverine, 1,6-diaminohexane), dicarboxylic acids (succinic, glutaric, adipic, and sebacic acids), and ω-amino acids (γ-aminobutyric, 5-aminovaleric, and 6-aminocaproic acids). Also, strategies for producing diols (monoethylene glycol, 1,3-propanediol, and 1,4-butanediol) and hydroxy acids (3-hydroxypropionic and 4-hydroxybutyric acids) used for polyesters are reviewed. Furthermore, we review strategies for producing aromatic monomers, including styrene, p-hydroxystyrene, p-hydroxybenzoic acid, and phenol, and propose pathways to aromatic polyurethane precursors. Finally, in vivo production of polyhydroxyalkanoates and recombinant structural proteins having interesting applications are showcased.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 23
Typ av publikation
tidskriftsartikel (18)
forskningsöversikt (4)
Typ av innehåll
refereegranskat (21)
övrigt vetenskapligt/konstnärligt (1)
Författare/redaktör
Farzadfar, F (8)
Jonas, JB (8)
Khang, YH (8)
Malekzadeh, R (8)
Schutte, AE (8)
Sepanlou, SG (8)
visa fler...
Shibuya, K (8)
Silva, DAS (8)
Kasaeian, A (8)
Qorbani, M (8)
Kengne, AP (8)
Zhou, B. (7)
Khader, YS (7)
Lotufo, PA (7)
Topor-Madry, R (7)
Lee, J. (7)
Cheng, CY (7)
Gudnason, V (7)
Wong, TY (7)
Ikram, MA (7)
Rahman, M (7)
Alkerwi, A. (7)
Parsaeian, M. (7)
Liu, J. (6)
Bruno, G. (6)
Peters, A (6)
Evans, A. (6)
Kim, J. (6)
Brenner, H (6)
Djalalinia, S (6)
Nagel, G (6)
Wagner, A. (6)
Amouyel, P (6)
Hofman, A (6)
Tzourio, C (6)
Simon, M. (6)
Cooper, C. (6)
Ferrieres, J (6)
Elliott, P (6)
Muller-Nurasyid, M. (6)
Vollenweider, P. (6)
Lehtimaki, T. (6)
Sundstrom, J (6)
Metspalu, A (6)
Salomaa, V (6)
Dallongeville, J (6)
Huybrechts, I (6)
Doring, A (6)
Franco, OH (6)
Bjertness, E (6)
visa färre...
Lärosäte
Karolinska Institutet (19)
Lunds universitet (12)
Umeå universitet (9)
Uppsala universitet (9)
Högskolan Dalarna (6)
Göteborgs universitet (5)
visa fler...
Kungliga Tekniska Högskolan (3)
Linköpings universitet (3)
Stockholms universitet (2)
Högskolan i Skövde (2)
Örebro universitet (1)
Jönköping University (1)
Södertörns högskola (1)
Chalmers tekniska högskola (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (23)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (17)
Naturvetenskap (5)
Teknik (1)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy